According to Paratek Pharmaceuticals 's latest financial reports the company's total assets are $0.14 B. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $0.17 B | -6.16% |
2021-12-31 | $0.18 B | 3.97% |
2020-12-31 | $0.17 B | -29.56% |
2019-12-31 | $0.25 B | -16.36% |
2018-12-31 | $0.30 B | 83.38% |
2017-12-31 | $0.16 B | 20.6% |
2016-12-31 | $0.13 B | -6.98% |
2015-12-31 | $0.14 B | 32.69% |
2014-12-31 | $0.10 B | 49.27% |
2013-12-31 | $73.67 M | -24.87% |
2012-12-31 | $98.05 M | 41.8% |
2011-12-31 | $69.15 M | -6.31% |
2010-12-31 | $73.8 M | -22.49% |
2009-12-31 | $95.21 M | 9.68% |
2008-12-31 | $86.81 M | -20.95% |
2007-12-31 | $0.10 B | 66.23% |
2006-12-31 | $66.06 M | 26.4% |
2005-12-31 | $52.26 M | 8.82% |
2004-12-31 | $48.03 M | |
2002-12-31 | $41.87 M | 980.29% |
2001-12-31 | $3.87 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Ultragenyx RARE | $1.49 B | 922.70% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | $0.10 B | -26.14% | ๐บ๐ธ USA |
Agenus
AGEN | $0.31 B | 115.32% | ๐บ๐ธ USA |